NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance · 1 week ago
Open | 16.21 |
High | 16.39 |
Low | 15.72 |
Mkt Cap | 1.74B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 16.03 |
52 Wk. Low | 10.87 |
52 Wk. High | 83.60 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 138.5M | 13.40% ▲ |
Net Income | -38.76M | - |
Diluted EPS | -0.36 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.43 | - |
Q1 2024 | -$0.42 | -$0.36 |
Q4 2023 | -$0.52 | -$0.45 |
S&P FuturesES=F | 5,244.00+5.00 (+0.10%) |
Dow FuturesYM=F | 39,583.00+47.00 (+0.12%) |
Nasdaq FuturesNQ=F | 18,226.75+12.25 (+0.07%) |
4.7500-1.25% | |
18.01+13.13% | |
30.42-22.06% |